Pharmaceutically acceptable salts of psilocin and uses thereof
AssigneeEleusis Therapeutics US, Inc.
InventorsDavid E. NICHOLS, Graham JOHNSON, Hooshang S. ZAVAREH, Claire WOMBWELL, Daniel RIXSON, Peter HADDOW, Carrie SHEARD, Alexander SCHWARZ
Life of this patent
Estimating the term…
Abstract
The present invention composition features pharmaceutically acceptable salts of psilocin and compositions thereof. The pharmaceutically acceptable salts of psilocin may be used to treat a disease or condition, such as a neurological injury, an inflammatory condition, chronic pain, or a psychological condition, in a subject in need thereof.
Claims23
A pharmaceutically acceptable salt of psilocin, wherein said pharmaceutically acceptable salt is a 1:1 benzoate salt, a 1:1 tartrate salt, a 2:1 succinate salt, a 2:1 salt of 1,5-naphthalenedisulfonic acid or a 1:1 salt of 1,5-naphthalenedisulfonic acid.
2-4. (canceled)
9-14. (canceled)
25-28. (canceled)
Dependencies are inferred from the claim text.